Comment by scoopertrooper

3 years ago

I just gave you a document containing 8 case studies where drugs were found to be not safe after having passed Phase 2 trials.

That happens after Phase 3 trials too.

This is about probabilities, and when lives are at stake, you should take some chances.

  • I would agree that drugs which have passed Phase 2 trials should made available to "mercy" patients during Phase 3 trials for patients that were not able to get into the trial...at cost to the pharmaceutical company that hopes to sell the drug/

    This would eliminate the profit motive that other commentators have noted would be a huge issue.